RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 21 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,000 | -16.7% | 19,616 | +19.8% | 0.00% | – |
| Q4 2015 | $6,000 | 0.0% | 16,374 | -5.1% | 0.00% | – |
| Q3 2015 | $6,000 | -53.8% | 17,248 | -34.9% | 0.00% | – |
| Q2 2015 | $13,000 | -31.6% | 26,502 | +2.4% | 0.00% | – |
| Q1 2015 | $19,000 | -53.7% | 25,881 | -0.1% | 0.00% | – |
| Q4 2014 | $41,000 | -8.9% | 25,903 | +147.8% | 0.00% | – |
| Q1 2014 | $45,000 | – | 10,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|